Cargando…
Case Report: Omalizumab Successfully Treated Recalcitrant Bullous Pemphigoid in an Elderly Patient with Multiple Comorbidities
Bullous pemphigoid (BP) is an autoimmune blistering disease mainly affecting elderly individuals. Comorbidities are common in patients with BP and have been found to complicate the management and prognosis. We describe a patient with multiple comorbidities who was successfully treated with omalizuma...
Autores principales: | Liu, Jue, Xiang, Tingkai, Wang, Wei, Bu, Zhangyu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9314756/ https://www.ncbi.nlm.nih.gov/pubmed/35903519 http://dx.doi.org/10.2147/CCID.S373682 |
Ejemplares similares
-
Case Report: Combination of Omalizumab and Dupilumab for Recalcitrant Bullous Pemphigoid
por: Seyed Jafari, S. Morteza, et al.
Publicado: (2021) -
Recalcitrant infantile bullous pemphigoid successfully treated with cyclosporine
por: Bar-Ilan, Efrat, et al.
Publicado: (2022) -
Increasing evidence for omalizumab in the treatment of bullous pemphigoid
por: Lonowski, Sarah, et al.
Publicado: (2020) -
Cutaneous Cytomegalovirus Infection Presenting As Recalcitrant Bullous Pemphigoid Lesion
por: Baek, Gayun, et al.
Publicado: (2023) -
Recalcitrant bullous pemphigoid responsive to dupilumab in an adolescent patient
por: Zhou, Albert E., et al.
Publicado: (2022)